Furthermore, the effects of extracellular NGB on ERα+/ERα− cancer cells and non-transformed epithelial mammary cells strongly sustain that the released globin can function in whole breast tumor environment, which commonly show a strong spatial and temporal heterogeneity in terms of cell composition [58]. Here, ESR1 is linked to cancer.